对偏头痛的精确目标发现:一个集成的GWAS-eQTL-PheWAS管道
Xianting Liu1, Qingming Liu1, Haoning Zhu1
1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
Molecules (Basel, Switzerland)
|October 16, 2025
概括
这项研究整合了遗传数据,以找到新的偏头痛药物标. 它优先考虑开发更有效,个性化偏头痛治疗的基因.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是一种令人衰弱的神经系统疾病,目前的治疗方法不足.
- 需要精准医学方法来开发有针对性的偏头痛疗法.
研究的目的:
- 通过多omics方法识别新的,可用药物治疗的偏头痛遗传标.
- 将遗传发现转化为潜在的偏头痛治疗策略.
主要方法:
- 综合全基因组关联研究 (GWAS) 和表达量化特征位置 (eQTL) 数据.
- 采用孟德尔的随机化 (SMR/HEIDI),局部化,蛋白与蛋白相互作用 (PPI) 网络和基因丰富分析.
- 利用全现象关联研究 (PheWAS) 来评估潜在的药物安全概况.
主要成果:
- 在全血和20个脑组织中确定了31个偏头痛相关基因,其中9个是共享的.
- 在局部化验证后优先考虑了10个可用药物的基因,其中8个与已知的药物标相互作用.
- 预测了41种潜在的可重用药物,并突出了NR1D1,THRA,NCOR2和CHD4以供进一步开发.
结论:
- 建立了精确偏头痛治疗的多omics框架.
- 确定了新的病理生理因素 (MICU1,UFL1,LY6G5C,PPP1CC) 和优先考虑的关键可药物标.
- 将遗传洞察力转化为改善偏头痛治疗的临床可行的目标.
相关概念视频
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...